APVO Financials

Aptevo Therapeutics Inc - Financial statements & key metrics

Stock Price

$4.42

Market Cap

$6.90M

P/E Ratio

0.0

EPS

$7758.20

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-24.13M

EPS (Diluted)

$-87.38

Balance Sheet Highlights

Total Assets

$15.59M

Total Liabilities

$10.84M

Shareholders Equity

Cash & Equivalents

$8.71M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-23.79M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-2.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is APVO revenue?

View APVO's income statement for detailed revenue data.

Is APVO profitable?

APVO reported a loss of $24.13M in the most recent quarter.

What is APVO market cap?

APVO has a market capitalization of $6.90M, making it a small-cap stock.

Does APVO have debt?

View APVO's balance sheet for debt information.

What is APVO cash flow?

Cash flow data is available in the full financial statements.